Markers of cardiac ischemia and inflammation

被引：7
作者：
Wang, TY
AlJaroudi, WA
Newby, LK
机构：
[1] Duke Clin Res Inst, Durham, NC 27715 USA
[2] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
来源：
CARDIOLOGY CLINICS | 2005年 / 23卷 / 04期
关键词：
D O I：
10.1016/j.ccl.2005.08.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Because biomarkers of myocardial necrosis only become positive in the setting of myocardial necrosis and disruption of cellular integrity, the diagnosis of myocardial infarction can only be made in retrospect. Ideally, one would like to identify patients at risk for complications before myocardial necrosis occurs. Insights into the pathophysiology of atherothrombosis have allowed development of novel markers to detect not only early ischemia without myocyte death but also early indicators of coronary inflammation in patients who have preclinical atherosclerosis.
引用
收藏
页码：491 / +
页数：12
相关论文
共 89 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[3]   CYTOKINES AND GROWTH-FACTORS POSITIVELY AND NEGATIVELY REGULATE INTERSTITIAL COLLAGEN GENE-EXPRESSION IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS [J].
AMENTO, EP ;
EHSANI, N ;
PALMER, H ;
LIBBY, P .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (05) :1223-1230
[4]   Role of serum amyloid A during metabolism of acute-phase HDL by macrophages [J].
Artl, A ;
Marsche, G ;
Lestavel, S ;
Sattler, W ;
Malle, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (03) :763-772
[5]   Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [J].
Ballantyne, CM ;
Hoogeveen, RC ;
Bang, H ;
Coresh, J ;
Folsom, AR ;
Heiss, G ;
Sharrett, AR .
CIRCULATION, 2004, 109 (07) :837-842
[6]   A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - A preliminary report [J].
Bar-Or, D ;
Lau, E ;
Winkler, JV .
JOURNAL OF EMERGENCY MEDICINE, 2000, 19 (04) :311-315
[7]   Pregnancy-associated plasma protein a as a marker of acute coronary syndromes [J].
Bayes-Genis, A ;
Conover, CA ;
Overgaard, MT ;
Bailey, KR ;
Christiansen, M ;
Holmes, DR ;
Virmani, R ;
Oxvig, C ;
Schwartz, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) :1022-1029
[8]   B-type natriuretic peptide and ischemia in patients with stable coronary disease - Data from the Heart and Soul Study [J].
Bibbins-Domingo, K ;
Ansari, M ;
Schiller, NB ;
Massie, B ;
Whooley, MA .
CIRCULATION, 2003, 108 (24) :2987-2992
[9]   A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events in women [J].
Blake, GJ ;
Dada, N ;
Fox, JC ;
Manson, JE ;
Ridker, PM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (05) :1302-1306
[10]   Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up [J].
Brilakis, ES ;
McConnell, JP ;
Lennon, RJ ;
Elesber, AA ;
Meyer, JG ;
Berger, PB .
EUROPEAN HEART JOURNAL, 2005, 26 (02) :137-144
123456789